Northern Trust Corp Evelo Biosciences, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.17 - $1.57 $108 - $1,004
-640 Reduced 0.67%
94,330 $16,000
Q4 2022

Feb 13, 2023
SELL
$1.44 - $48.2 $434 - $14,556
-302 Reduced 0.32%
94,970 $152,000
Q3 2022

Nov 14, 2022
BUY
$1.86 - $41.8 $43,034 - $967,126
23,137 Added 32.07%
95,272 $199,000
Q2 2022

Aug 12, 2022
SELL
$1.46 - $3.55 $313,660 - $762,667
-214,836 Reduced 74.86%
72,135 $152,000
Q1 2022

May 13, 2022
SELL
$2.66 - $6.63 $35,816 - $89,272
-13,465 Reduced 4.48%
286,971 $973,000
Q4 2021

Feb 08, 2022
BUY
$6.07 - $12.0 $13,961 - $27,600
2,300 Added 0.77%
300,436 $1.82 Million
Q3 2021

Nov 15, 2021
SELL
$6.79 - $13.9 $166,456 - $340,758
-24,515 Reduced 7.6%
298,136 $2.1 Million
Q2 2021

Aug 13, 2021
BUY
$9.43 - $16.6 $639,080 - $1.12 Million
67,771 Added 26.59%
322,651 $4.43 Million
Q1 2021

May 12, 2021
BUY
$9.71 - $18.6 $259,354 - $496,806
26,710 Added 11.71%
254,880 $2.73 Million
Q4 2020

Feb 11, 2021
BUY
$3.91 - $12.28 $18,775 - $58,968
4,802 Added 2.15%
228,170 $2.76 Million
Q3 2020

Nov 16, 2020
BUY
$3.81 - $5.73 $189,467 - $284,947
49,729 Added 28.64%
223,368 $1.18 Million
Q2 2020

Aug 14, 2020
BUY
$3.53 - $6.12 $85,189 - $147,693
24,133 Added 16.14%
173,639 $851,000
Q1 2020

May 14, 2020
BUY
$3.21 - $7.06 $31,666 - $69,646
9,865 Added 7.06%
149,506 $561,000
Q4 2019

Feb 14, 2020
BUY
$3.81 - $7.45 $2,476 - $4,842
650 Added 0.47%
139,641 $567,000
Q3 2019

Nov 13, 2019
SELL
$5.45 - $8.8 $1,139 - $1,839
-209 Reduced 0.15%
138,991 $847,000
Q2 2019

Aug 13, 2019
BUY
$6.52 - $9.42 $14,357 - $20,742
2,202 Added 1.61%
139,200 $1.25 Million
Q1 2019

May 13, 2019
BUY
$7.5 - $15.31 $66,322 - $135,386
8,843 Added 6.9%
136,998 $1.1 Million
Q4 2018

Feb 12, 2019
BUY
$7.29 - $13.01 $509,024 - $908,423
69,825 Added 119.71%
128,155 $1.67 Million
Q3 2018

Nov 14, 2018
BUY
$11.93 - $14.76 $466,260 - $576,865
39,083 Added 203.06%
58,330 $711,000
Q2 2018

Aug 14, 2018
BUY
$11.39 - $16.26 $219,223 - $312,956
19,247 New
19,247 $227,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email